Two companies co-founded by UI researchers have secured a combined $62 million in financing to advance disease therapies.
The companies, Carbon Biosciences and hC Bioscience, are based on foundational research by University of Iowa (UI) professors John Engelhardt, Ziying Yan, Chris Ahern, and colleagues at other institutions.
A representative with Ximbio, the world’s largest non-profit dedicated to broadening access to life science research tools, will be available at the University of Iowa Research Foundation (UIRF) table during the Research Services Fair Oct. 10.
If a tree falls in the woods and no one is around to sees it, did it happen? And if researchers make discoveries with commercial potential but don’t protect and license their inventions, will they ever reach the market?
Unlikely, says University of Iowa Research Foundation (UIRF) Executive Director Marie Kerbeshian, who is also an assistant vice president in the Office of the Vice President for Research (OVPR).
